'Caspases' are
enzymes known as
proteases, which play essential roles in
apoptosis (cell death) and
inflammation. As proteases, they are enzymes that cleave (cut) other proteins. They are called
cysteine proteases, because they use a
cysteine residue to cut those proteins, and called caspases because the cysteine residue cleaves their
substrate proteins at the
aspartic acid residue.
Caspases are essential in
cells for
apoptosis, one of the main types of programmed cell death in
development and most other stages of adult life, and have been termed "executioner" proteins for their roles in the cell. Some caspases are also required in the
immune system for the maturation of
cytokines. Failure of apoptosis is one of the main contributions to
tumour development and autoimmune diseases; this coupled with the unwanted apoptosis that occurs with
ischaemia or
Alzheimer's disease, has boomed the interest in caspases as potential therapeutic targets since they were discovered in the mid 1990s.
Types of caspase proteins
Eleven caspases have so far been identified in humans. There are two types of apoptotic caspases: 'initiator (apical) caspases' and 'effector (executioner) caspases'.
★ Initiator caspases (e.g. , , and cleave inactive pro-forms of effector caspases, thereby activating them.
★ Effector caspases (e.g. , , in turn cleave other protein substrates within the cell resulting in the apoptotic process. The initiation of this cascade reaction is regulated by caspase inhibitors.
and , which are overexpressed in some cases of
vitiligo and associated autoimmune diseases caused by NALP1 variants,
[1] are not currently classified as initiator or effector in
Mesh. This is because they are 'inflammatory' caspases, which in concert with , are involved in cytokine maturation. , is not involved in apoptosis or inflammation, but instead is involved in skin cell development.
The caspase cascade
Caspases are regulated at a
post-translational level, ensuring that they can be rapidly activated. They are first synthesized as inactive ''pro-caspases'', that consist of a prodomain, a small subunit and a large subunit. Initiator caspases possess a longer prodomain than the effector caspases, whose prodomain is very small. The prodomain of the initiator caspases contain domains such as a
CARD domain (e.g. caspases-2 and -9) or a
death effector domain (DED) (caspases-8 and -10) that enables the caspases to interact with other molecules that regulate their activation. These molecules respond to stimuli which cause the clustering of the initiator caspases. This allows them to autoactivate, so that they can then proceed to activate the effector caspases.
The caspase cascade can be activated by :
★
Granzyme B (released by
cytotoxic T lymphocytes) which is known to activate caspase-3 and -7
★ death receptors (like
FAS,
TRAIL receptors and
TNF receptor) which can activate caspase-8 and -10
★ the
apoptosome (regulated by
cytochrome c and the
Bcl-2 family) which activates
caspase-9.
Some of the final targets of caspases include:
★ nuclear
lamins
★ ICAD/DFF45 ('I'nhibitor of 'C'aspase 'A'ctivated 'D'Nase or 'D'NA 'F'ragmentation 'F'actor 45)
★ PARP ('P'oly('A'DP) 'R'ibose 'P'olymerase)
★ PAK2 ('P'21-'A'ctivated 'K'inase 2).
The exact contribution that the cleavage of many caspase substrates makes to the biochemistry and morphology of apoptosis is unclear. However, the function of ICAD/DFF45 is to restrain the enzyme CAD (Caspase Activated DNase). The cleavage and inactivation of ICAD/DFF45 by a caspase allows CAD to enter the nucleus and fragment the DNA, causing the characteristic 'DNA ladder' seen in apoptotic cells.
Discovery of caspases, their functions and roles
The importance of caspases to apoptosis and programmed cell death was originally established by
Robert Horvitz and colleagues who found that the ''ced-3'' gene was required for the cell death that took place during the development of the
nematode ''
C. elegans''. Horvitz and his colleague Junying Yuan found in
1993 that the protein encoded by the ced-3 gene was a cysteine protease with similar properties to the
mammalian interleukin-1-beta converting enzyme (ICE) (now known as caspase 1) which at the time was the only known caspase. Following this discovery, the other mammalian caspases, in addition to caspases in other organisms such as the fruit fly ''
Drosophila melanogaster'', were soon identified and characterised. A consortium of researchers in the field decided upon the caspase nomenclature early in
1996, as in many instances a particular caspase had been identified simultaneously by more than one lab, who would each give the protein a different name (e.g. caspase 3 was variously known as CPP32, apopain and Yama). The caspases are numbered in the order in which they were identified, hence the renaming of ICE to caspase 1. Ironically, although ICE was the first mammalian caspase to be characterised due to its similarity to the nematode death gene ced-3, it seems that the principal role for this enzyme is in mediating inflammation rather than in cell death.
For overviews of the discovery of not just caspases but other aspects of apoptosis see articles by Danial and Korsmeyer,
[2] Yuan and Horvitz,
[3] and by Li et al.
[4] in the January 23rd 2004 edition of the journal '
Cell'.
See also
★
Apoptosis
★
pyroptosis
★
Bcl-2
★
Apoptosome
★
paracaspase
★
metacaspase
References
1. Modern genetics, ancient defenses, and potential therapies., , P.K., Gregersen, N Engl J Med., 2007 [PMID 17377166]
2.
Cell Death: Critical Control Points, , N. N., Danial, Cell, 2004
3.
A First Insight into the Molecular Mechanisms of Apoptosis, , J., Yuan, Cell, 2004
4.
Mitochondrial Activation of Apoptosis, , P., Li, Cell, 2004
External links
★
The Mechanisms of Apoptosis Kimball's Biology Pages. Simple explanation of the mechanisms of apoptosis triggered by internal signals (bcl-2), along the caspase-9, caspase-3 and caspase-7 pathway; and by external signals (FAS and TNF), along the caspase 8 pathway. Accessed 25 March 2007.
★
Caspase antibody review
★